Hussein Hollands1, Sanjay Sharma
1Cost-effective Ocular Health Policy Unit, Queens University, Kingston, Ontario, Canada.
This review summarizes recent cost-utility studies for retina/vitreous treatments, including age-related macular degeneration and diabetic retinopathy. Cost-effectiveness analyses are increasingly used to compare ophthalmic interventions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: